Aether Industries (Aether) has entered into a manufacturing agreement with Chemoxy International, a wholly-owned subsidiary of the Seqens Group. 

Under this contract, Aether will produce a series of natural bio-based products exclusively for Seqens over an initial period of three years. The production is expected to commence over the next 10 months with 100+ MT per year output. The manufacturing process involves a complex process and continuous reaction technology, and has been collaboratively developed by Aether and Seqens over the past three years.

This venture marks a milestone for Aether’s Renewables and Sustainability business segment, and solidifying its position as a speciality chemical manufacturer and provider of sustainable and carbon-neutral chemistry solutions. Headquartered in France, the Seqens Group is an integrated global leader in health, personal care, and speciality ingredients, operating 16 production sites and nine R&D centres worldwide.